Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1/2 2Phase NA 1

Status

Completed 8Recruiting 5Active not recruiting 4Terminated 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

CNS 5

Conditions

Breast Neoplasms 311Carcinoma, Non-Small-Cell Lung 282Prostatic Neoplasms 160Colorectal Neoplasms 155Carcinoma, Hepatocellular 144Neoplasms 134Leukemia, Myeloid, Acute 132Lung Neoplasms 115Squamous Cell Carcinoma of Head and Neck 108Triple Negative Breast Neoplasms 102Multiple Myeloma 102Recurrence 99Pancreatic Neoplasms 94Stomach Neoplasms 93Ovarian Neoplasms 87Neoplasm Metastasis 87Lymphoma, Large B-Cell, Diffuse 81Sarcoma 70Precursor Cell Lymphoblastic Leukemia-Lymphoma 68Esophageal Neoplasms 67Uterine Cervical Neoplasms 66Melanoma 65Brain Neoplasms 65Rectal Neoplasms 62Head and Neck Neoplasms 62Glioblastoma 60Carcinoma, Renal Cell 57Lymphoma 55Myelodysplastic Syndromes 54Esophageal Squamous Cell Carcinoma 54

Interventions

trametinib 1tovorafenib 1tocilizumab 1dabrafenib 1binimetinib 1Qsymia 1Phentermine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Recruiting × Craniopharyngioma × Clear all
NCT05233397 2026-04-23

ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

Nationwide Children's Hospital

Phase 2 Recruiting
30 enrolled
CNS

Craniopharyngioma

NCT05465174 2026-04-23

PNOC029

University of California, San Francisco

Phase 2 Recruiting
57 enrolled
CNS

Craniopharyngioma

NCT05286788 2026-04-08

MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

Nationwide Children's Hospital

Phase 2 Recruiting
38 enrolled
CNS

Craniopharyngioma

NCT06299891 2025-07-28

Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity

Seattle Children's Hospital

Phase 2 Recruiting
24 enrolled
CNS

Craniopharyngioma, Hypothalamic Neoplasms, Sexual Infantilism

NCT05525273 2024-02-14

Swecranio

Skane University Hospital

Phase 2 Recruiting
25 enrolled
CNS

Craniopharyngioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡